Procedural and clinical evaluation of the novel zotarolimus-eluting resolute® stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: A multicenter registry

Journal of Invasive Cardiology

Volumn 23, Issue 2, 2011, Pages 50-54

  Tommasino, Antonella ^a   Burzotta, Francesco ^a   Sciahbasi, Alessandro ^b   Trani, Carlo ^a   De Vita, Maria ^c   Romagnoli, Enrico ^b   Lioy, Ernesto ^b   Tarantino, Fabio ^c   Summaria, Francesco ^b   Leone, Antonio Maria ^a   Porto, Italo ^a   Niccoli, Giampaolo ^a   Mongiardo, Rocco ^a   Mazzari, Mario Attilio ^a   Schiavoni, Giovanni ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c Ospedale Morgani   (Italy)

Author keywords

bifurcation lesions; provisional approach; Resolute stent

Indexed keywords

ZOTAROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; IMPLANT REGISTRY; IN-STENT RESTENOSIS; INTRAOPERATIVE PERIOD; ITALY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MONITORING; MUSCLE NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SURGICAL APPROACH; SURVIVAL RATE; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME; ZOTAROLIMUS ELUTING STENT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79957609035     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-1249. (Pubitemid 38372783)
2. Pan M, Suárez de Lezo J, Medina A, et al. Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007;153:E1-E7.
3. Song YB, Hahn JY, Choi SH, et al. Sirolimus-versus paclitaxel-eluting stents for the treatment of coronary bifurcations: Results from the COBIS (Coronary Bifurcation Stenting) Registry. J Am Coll Cardiol 2010;55:1743-1750.
4. Meredith I T, Worthley S, Whitbourn R, et al., for the RESOLUTE Investigators.Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv 2009;2:977-985.
5. Meredith IT, Worthley SG, Whitbourn R, et al. Long-term clinical outcomes with the next-generation Resolute stent system: A report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention 2010;5:692-697.
6. Serruys P W, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010;363:136-146. Epub 2010 Jun 16.
7. Brugaletta S, Burzotta F, Sabaté M. Zotarolimus for the treatment of coronary artery disease: Pathophysiology, DES design, clinical evaluation and future perspective. Expert Opin Pharmacother 2009;10:1047-1058.
8. Ormiston JA, Webster MW, El Jack S, et al. Drug-eluting stents for coronary bifurcations: Bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv 2006;67:49-55. (Pubitemid 43062609)
9. Mortier P, Van Loo D, De Beule M, et al. Comparison of drug-eluting stent cell size using micro-CT: Important data for bifurcation stent selection. EuroIntervention 2008;4:391-396.
10. Burzotta F, Sgueglia GA, Trani C, et al. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: One-year clinical results of a prospective registry. J Invasive Cardiol 2009;21:532-537.
11. Burzotta F, Gwon HC, Hahn JY, et al. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: The T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Catheter Cardiovasc Interv 2007;70:75-82. (Pubitemid 47035998)
12. Cutlip DE, Windecker S, Mehran R, et al., for the Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
13. Stankovic G, Darremont O, Ferenc M, et al., for the European Bifurcation Club. Percutaneous coronary interventions for bifurcation lesions: 2008 consensus document from the fourth meeting of the European Bifurcation Club: Eurointervention 2009;5:39-49.
14. Louvard Y, Thomas M, Dzavik V, et al. Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! Catheter Cardiovasc Interv 2008;71:175-183. (Pubitemid 351293761)
15. Burzotta F, Trani C. TAP stenting: An intuitive and practical technique to treat bifurcated lesions in the hands of different operators. Catheter Cardiovasc Interv 2010;75:979-980.
16. Al Rashdan I, Amin H. Carina modification T stenting, a new bifurcation stenting technique: Clinical and angiographic data from the first 156 consecutive patients. Catheter Cardiovasc Interv 2009;74:683-690.
17. Hahn JY, Song YB, Lee SY, et al. Serial intravascular ultrasound analysis of the main and side branches in bifurcation lesions treated with the T-stenting technique. J Am Coll Car-diol 2009;54:110-117.
18. Cheng WJ, Zhou YJ, Zhao YX, et al. Randomized study on T stenting and small protrusion technique versus simple stenting for patients with coronary artery bifurcation lesions and with big size side branch. Zhonghua Xin Xue Guan Bing Za Zhi 2010;38:131-134.
19. Sgueglia GA, Burzotta F, Trani C, et al. Comparative assessment of mTOR in-hibitor-eluting stents in the treatment of coronary artery bifurcation lesions: The CASTOR-Bifurcation Registry. Catheter Cardiovasc Interv 2010 Jul 2 (Epub ahead of print).